Oral Minoxidil HSA/FSA Eligibility and Submission: What You Need to Know in 2026
At a glance
- Form / prescription minoxidil tablets; Loniten 2.5 mg and 10 mg are marked discontinued, and generic tablets remain on the market [3]
- Approved indication / hypertension not manageable with a diuretic plus two other antihypertensive drugs [1]
- Hair-loss use / the label states hair-growth use is not an approved indication [1]
- OTC alternative / topical Rogaine, over the counter since the 1996 switch [4]
- Federal guidance on qualified medical expenses / IRS Publication 969, covering HSAs and FSAs [2]
- Current tablet labeling / generic labeling effective June 11, 2026 [1]
Is Oral Minoxidil HSA or FSA Eligible?
IRS Publication 969 is the federal reference for qualified medical expenses under HSAs and health FSAs [2]. Oral minoxidil taken for hair loss is an unapproved use of the tablet, since the label does not approve use to promote hair growth [1]. This page cannot say how that status plays out for an HSA or FSA claim.
What the Prescription Actually Is
Minoxidil tablets were approved on October 18, 1979, as NDA 018154 (Loniten, Pfizer) [3]. The Loniten 2.5 mg and 10 mg tablets are now marked discontinued in Drugs@FDA, with an FDA determination that this was not for safety or effectiveness reasons. Generic minoxidil tablets remain on the market [3].
The indication on the current generic label is hypertension that is symptomatic or associated with target organ damage and not manageable with maximum doses of a diuretic plus two other antihypertensive drugs. The label says use in milder hypertension is not recommended [1]. The same label states that use of minoxidil tablets, in any formulation, to promote hair growth is not an approved indication [1].
Off-Label Use and Dose
FDA says that once a drug is approved, healthcare providers generally may prescribe it for an unapproved use when they judge it medically appropriate. FDA has not determined that the drug is safe and effective for that unapproved use [5].
For hypertension, the label starts treatment at 5 mg once daily, with a usual effective range of 10 to 40 mg per day [1]. Hair-loss trials have used 1 mg and 5 mg daily [6][7].
Oral Tablets and Rogaine Are Regulated Differently
Rogaine 2% solution received its prescription-to-OTC switch on February 9, 1996 [4]. The 5% Rogaine products were approved later and are also labeled over the counter [4]. Oral minoxidil tablets are prescription tablets approved for hypertension [1].
Frequently asked questions
Is oral minoxidil HSA or FSA eligible?
Is oral minoxidil FDA approved for hair loss?
How is oral minoxidil different from Rogaine?
References
- U.S. National Library of Medicine, DailyMed. Minoxidil tablets (oral), Par Health prescribing information. Minoxidil tablets (oral), Par Health label
- Publication 969 (2025), Health Savings Accounts and Other Tax-Favored Health Plans | Internal Revenue Service. Publication 969 (2025), Health Savings Accounts and Other Tax-Favored Health Plans | Internal Revenue Service
- Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
- Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
- Understanding Unapproved Use of Approved Drugs "Off Label" | FDA. Understanding Unapproved Use of Approved Drugs "Off Label" | FDA
- Asilian A, Farmani A, Saber M. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial. J Cosmet Dermatol. 2024;23(3):949-957. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial
- Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatol. 2024;160(6):600-605. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial